Product Overview
A40926 is a natural glycopeptide antibiotic and a precursor for the semi-synthesis of dalbavancin. Dalbavancin is designed to be an improved alternative to those antibiotics, or the treatment of patients infected with MRSA (methicillin-resistant Staphyloccous aureus) and MRSE (methicillin-resistant Staphylococcus epidermidis).
Features
Ready-to-use product, accelerating research progress, enhancing application performance.
Applications
Industrial Applications
Production Methods
Fermentation
Shipping
Timely shipping by optional means
Fermentation Time
216±12hrs
Specification
Standard and Custom Specifications